Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. Late-Stage Prostate Cancer Treatment Strengthens...
The companies have expanded their strategic relationship formed in 2010
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in...
Novartis drug Jakavi® improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease Jakavi® reduced risk of...
After years of anticipation and considerable debate, the US Supreme Court has ruled that drugmakers can face lawsuits over so-called pay-to-delay...
We have a midday meeting, but do not want you to feel abandoned as we head off for a little while. And so here are a few developments that caught our eye. See you soon...
Sepracor Gets OK To Market Lunesta In Europe (Boston.com)
Europe Rejects Lilly Drug For Fibromyalgia (Yahoo/Reuters)
